Appropriations to fund the FDA implementation of compounding pharmacy regulations.
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation yet.
Proposals to amend the Controlled Substances Act to clarify the definition of dispense to include the delivery of a controlled substance by a practitioner acting in the usual course of professional practice. No specific legislation yet.
Duration: May 23, 2013
to
March 31, 2015
General Issues: Budget/Appropriations , Health Issues , Law Enforcement/Crime/Criminal Justice , Pharmacy , Medical/Disease Research/Clinical Labs
Spending: about $0 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2013: U.S. Senate, House of Representatives
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
James Rock
Staff Asst, US House Committee on Budget - 1985 to 2000
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2015
Rock & Associates terminated an engagement in which they represented Capitol Hill Consulting Group (on behalf of Wellness Pharmacy) on April 19, 2016.
Original Filing: 300795402.xml
Lobbying Issues
Appropriations to fund the FDA implementation of compounding pharmacy regulations.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation yet.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Proposals to amend the Controlled Substances Act to clarify the definition of dispense to include the delivery of a controlled substance by a practitioner acting in the usual course of professional practice. No specific legislation yet.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Law Enforcement/Crime/Criminal Justice
1st Quarter, 2015
In Q1, Rock & Associates lobbied for Capitol Hill Consulting Group (on behalf of Wellness Pharmacy) . The report was filed on April 7, 2015.
Original Filing: 300712969.xml
Lobbying Issues
Appropriations to fund the FDA implementation of compounding pharmacy regulations.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation yet.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Proposals to amend the Controlled Substances Act to clarify the definition of dispense to include the delivery of a controlled substance by a practitioner acting in the usual course of professional practice. No specific legislation yet.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Law Enforcement/Crime/Criminal Justice
4th Quarter, 2014
Rock & Associates terminated an engagement in which they represented Capitol Hill Consulting Group (on behalf of Wellness Pharmacy) on July 14, 2015.
Original Filing: 300733786.xml
Lobbying Issues
Appropriations to fund the FDA implementation of compounding pharmacy regulations. H.R. 4800 and S. 2437.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation yet.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Proposals to amend the Controlled Substances Act to clarify the definition of dispense to include the delivery of a controlled substance by a practitioner acting in the usual course of professional practice. No specific legislation yet.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Law Enforcement/Crime/Criminal Justice
4th Quarter, 2014
In Q4, Rock & Associates lobbied for Capitol Hill Consulting Group (on behalf of Wellness Pharmacy) . The report was filed on Jan. 13, 2015.
Original Filing: 300694669.xml
Lobbying Issues
Appropriations to fund the FDA implementation of compounding pharmacy regulations. H.R. 4800 and S. 2437.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation yet.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Proposals to amend the Controlled Substances Act to clarify the definition of dispense to include the delivery of a controlled substance by a practitioner acting in the usual course of professional practice. No specific legislation yet.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Law Enforcement/Crime/Criminal Justice
3rd Quarter, 2014
In Q3, Rock & Associates lobbied for Capitol Hill Consulting Group (on behalf of Wellness Pharmacy) . The report was filed on Oct. 9, 2014.
Original Filing: 300674824.xml
Lobbying Issues
Appropriations to fund the FDA implementation of compounding pharmacy regulations. H.R. 4800 and S.2437.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation yet.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Proposals to amend the Controlled Substances Act to clarify the definition of "dispense" to include the delivery of a controlled substance by a practitioner acting in the usual course of professional practice. No specific legislation yet.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Law Enforcement/Crime/Criminal Justice
2nd Quarter, 2014
In Q2, Rock & Associates lobbied for Capitol Hill Consulting Group (on behalf of Wellness Pharmacy) . The report was filed on July 15, 2014.
Original Filing: 300656622.xml
Lobbying Issues
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation yet.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Appropriations to fund the FDA implementation of compounding pharmacy regulations. H.R. 4800 and S.2437.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2014
In Q1, Rock & Associates lobbied for Capitol Hill Consulting Group (on behalf of Wellness Pharmacy) . The report was filed on April 15, 2014.
Original Filing: 300635814.xml
Lobbying Issues
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation yet.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Appropriations to fund the FDA implementation of compounding pharmacy regulation. No specific legislation yet.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
4th Quarter, 2013
In Q4, Rock & Associates lobbied for Capitol Hill Consulting Group (on behalf of Wellness Pharmacy) . The report was filed on Jan. 13, 2014.
Original Filing: 300613152.xml
Lobbying Issues
S.959, H.R. 3089 & H.R. 3204 legislation affecting the operation of compounding pharmacies and the availability of compounded medications.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
S.959, H.R. 3089 & H.R. 3204, legislation affecting the operation of compounding pharmacies and the availability of compounded medications.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs Pharmacy
3rd Quarter, 2013
In Q3, Rock & Associates lobbied for Capitol Hill Consulting Group (on behalf of Wellness Pharmacy) . The report was filed on Oct. 8, 2013.
Original Filing: 300591441.xml
Lobbying Issues
S.959, H.R. 3089 & H.R. 3204 legislation affecting the operation of compounding pharmacies and the availability of compounded medications.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
S.959, H.R. 3089 & H.R. 3204, legislation affecting the operation of compounding pharmacies and the availability of compounded medications.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs Pharmacy
2nd Quarter, 2013
Rock & Associates filed a lobbying registration on July 14, 2013 to represent Capitol Hill Consulting Group (on behalf of Wellness Pharmacy), effective May 23, 2013.
Original Filing: 300572175.xml
Issue(s) they said they’d lobby about: Issues related to the operation of compounding pharmacies and the availability of compounded medications. .
2nd Quarter, 2013
In Q2, Rock & Associates lobbied for Capitol Hill Consulting Group (on behalf of Wellness Pharmacy) . The report was filed on July 15, 2013.
Original Filing: 300572410.xml
Lobbying Issues
S.959, legislation affecting the operation of compounding pharmacies and the availability of compounded medications.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Health Issues Medical/Disease Research/Clinical Labs Pharmacy
2nd Quarter, 2013
Rock & Associates filed a lobbying registration on July 1, 2013 to represent Capitol Hill Consulting Group (on behalf of Wellness Pharmacy), effective May 23, 2013.
Original Filing: 300568952.xml
Issue(s) they said they’d lobby about: Issues related to the operation of compounding pharmacies and the availability of compounded medications. .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate